Editorial Comment

J Urol. 2018 Sep;200(3):580. doi: 10.1016/j.juro.2018.03.159. Epub 2018 Jun 11.

Author

Jehonathan H Pinthus¹

Affiliation

¹ Division of Urology, Department of Surgery, McMaster University, Toronto, Ontario, Canada.

PMID: 29902426
DOI: 10.1016/j.juro.2018.03.159

No abstract available

Publication types

Comment

MeSH terms

Androgen Antagonists
Humans
Liver Diseases*
Male
Prostatic Neoplasms*

Substances

Androgen Antagonists